Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia/Melbourne School of Population & Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Mult Scler. 2023 Jul;29(8):1012-1023. doi: 10.1177/13524585231167739. Epub 2023 May 6.
A pro-inflammatory diet has been posited to induce chronic inflammation within the central nervous system (CNS), and multiple sclerosis (MS) is an inflammatory disease of the CNS.
We examined whether Dietary Inflammatory Index (DII) scores are associated with measures of MS progression and inflammatory activity.
A cohort with a first clinical diagnosis of CNS demyelination was followed annually (10 years, = 223). At baseline, 5- and 10-year reviews, DII and energy-adjusted DII (E-DII) scores were calculated (food frequency questionnaire) and assessed as predictors of relapses, annualised change in disability (Expanded Disability Status Scale) and two magnetic resonance imaging measures; fluid-attenuated inversion recovery (FLAIR) lesion volume and black hole lesion volume.
A more pro-inflammatory diet was associated with a higher relapse risk (highest vs. lowest E-DII quartile: hazard ratio = 2.24, 95% confidence interval (CI) = -1.16, 4.33, = 0.02). When we limited analyses to those assessed on the same manufacturer of scanner and those with a first demyelinating event at study entry (to reduce error and disease heterogeneity), an association between E-DII score and FLAIR lesion volume was evident (β = 0.38, 95% CI = 0.04, 0.72, = 0.03).
There is a longitudinal association between a higher DII and a worsening in relapse rate and periventricular FLAIR lesion volume in people with MS.
促炎饮食被认为会在中枢神经系统(CNS)内引发慢性炎症,而多发性硬化症(MS)是一种 CNS 的炎症性疾病。
我们研究了膳食炎症指数(DII)评分是否与 MS 进展和炎症活动的测量值相关。
对首次临床诊断为 CNS 脱髓鞘的队列进行了每年一次的随访(10 年,共 223 人)。在基线、5 年和 10 年回顾时,计算了 DII 和能量调整后的 DII(E-DII)评分(食物频率问卷),并将其评估为复发、残疾的年化变化(扩展残疾状况量表)和两种磁共振成像测量值的预测因子;液体衰减反转恢复(FLAIR)病变体积和黑洞病变体积。
更促炎的饮食与更高的复发风险相关(最高与最低 E-DII 四分位数相比:风险比=2.24,95%置信区间(CI)=−1.16,4.33,=0.02)。当我们将分析仅限于在同一扫描仪制造商上进行评估的患者和在研究入组时首次发生脱髓鞘事件的患者时(以减少误差和疾病异质性),E-DII 评分与 FLAIR 病变体积之间的关联变得明显(β=0.38,95%CI=0.04,0.72,=0.03)。
在 MS 患者中,较高的 DII 与复发率的增加和脑室周围 FLAIR 病变体积的恶化之间存在纵向关联。